Cortical Atrophy is Associated with Accelerated Cognitive Decline in Mild Cognitive Impairment with Subsyndromal Depression

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2017
Source ID
10.1016/j.jagp.2017.04.011

Entities

People

  • Craig Nelson
  • David Bickford
  • Duygu Tosun
  • Michael W. Weiner
  • Mitzi M. Gonzales
  • Niklas Mattsson
  • Philip S Insel
  • R. Scott Mackin
  • Simona Sacuiu
  • Susanne G Mueller

Organizations

  • Abbott Laboratories
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • Biogen
  • Bristol Myers Squibb (Canada)
  • Bristol-Myers Squibb
  • California Department of Public Health
  • Cornell University
  • Dana Foundation
  • Eli Lilly and Company
  • Food and Drug Administration
  • GE HealthCare
  • GSK
  • Innogenetics
  • Johns Hopkins Medicine
  • Johnson & Johnson
  • Kyoto University
  • Medpace
  • Memorial Sloan Kettering Cancer Center
  • Merck & Co.
  • National Brain Research Centre
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute of Mental Health
  • National Institute on Aging
  • National Institutes of Health
  • New York Academy of Sciences
  • Northwestern University
  • Novartis
  • Perrigo Company Plc
  • Pfizer
  • Roche (United States)
  • The Michael J. Fox Foundation
  • The Rockefeller University
  • United States Department of Defense
  • University of California, Los Angeles
  • University of California, San Diego
  • University of Pennsylvania
  • University of Tokyo